Articles On Cann Group (ASX:CAN)

The MGC Pharmaceuticals Ltd (ASX: MXC) share price has been a positive performer on Tuesday. In morning trade the cannabis company’s shares are up 3% to 3.5 cents. Why is the MGC Pharma share price charging higher? Investors have been buyi...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

In afternoon trade the S&P/ASX 200 index is fighting hard and pushing higher. At the time of writing the benchmark index is up 0.2% to 6,781 points. Four shares that have failed to follow the market higher today are listed below. Here’...

Lately, cannabis stocks in the US have come under pressure, following the rising death toll from vaping that reached 42 so far in 2019, according to media reports. Meanwhile, in Canada, Canopy Growth unveiled that returned cannabis oil prod...

The market may be trading lower today, but one group of shares is falling more than most – the cannabis companies. In early afternoon trade the cannabis industry is a sea of red as investors head for the exits in their droves. Here’s a sum...

Cannabis is a dynamic and rapidly growing sector with strong growth prospects. Countries like Canada, Germany, Norway, Thailand, Chile, Argentina, and Greece have legalised the use of medicinal cannabis, after recognizing its possible benef...

In morning trade the Althea Group Holdings Ltd (ASX: AGH) share price has raced higher following the release of an update. At the time of writing the cannabis company’s shares are up 7% to 51 cents. Why is the Althea share price on a high...

Cannabis Industry The Australian cannabis industry is the newest and the most dynamic sector after the legalization of cannabis for medicinal as well as recreational purposes. The cannabis industry refers to the activities and all the profe...

For the first time, England’s NHS approved the use of cannabis medicines to treat epilepsy and multiple sclerosis. And the industry is now pushing for CBD and THC to be allowed to be prescribed in more cases. The timing is curious, only a f...

The number of Australian patients being subscribed medicinal cannabis has risen a gigantic 1,191 per cent year-on-year, according to new data. Some 14,357 patients were approved medicinal cannabis, compared with 1,112 this time last year, a...

It ain’t easy bein’ green at the moment: more than 70 per cent of ASX-listed pot stocks have lost value so far in the 2020 financial year, a Stockhead analysis has found. The dire statistics fall against a wider backdrop of malaise in the g...

Pot stock Cann Group (ASX:CAN) has “moved into the commercialisation phase” — but it’s with imported products, as it continues to wait for approval for its own products from Australian regulators. Shares in Cann Group closed at $1.01 yester...

More than 20,000 Australians have been approved to use medical cannabis to treat conditions including cancer pain, chemotherapy-induced vomiting, drug-resistant epilepsy and anorexia

Marijuana stocks or pot stocks are catching investors’ eyes these days after the legalisation of cannabis for medicinal and recreational use in many countries.  According to the Australian health department, all the cannabis formulations su...

One of Australia's leading medicinal cannabis companies has all its ducks lined up in a row. Melbourne-based Cann Group (ASX: CAN) has today announced the signing of a nationwide distribution deal with healthcare services and products sup...

The Cann Group Ltd (ASX: CAN) share price is having a rare positive day of trade. In morning trade the cannabis company’s shares are up 4% to $1.05. This has reduced its one-month decline to approximately 30%. Why is the Cann Group share p...

Cannabis Shares Valuing a cannabis company is becoming an increasingly difficult task. Lately, the cannabis shares have been taking a beat in the domestic markets, falling from their respective all-time highs. The table below provides you w...

ASX cannabis shares have fallen out of favour recently, with the Althea Group (ASX: AGH), Cann Group Ltd (ASX: CAN) and Elixinol Global Ltd (ASX: EXL) share prices all tumbling to new lows. However, there is one cannabis share that has...

Each Monday, Stockhead recaps which stocks are most heavily in demand by investors — running hot. The analysis is based on the Relative Strength Index (RSI), a technical gauge which measures how trading momentum is affecting the price actio...

It’s been a year of highs and lows for cannabis shares. Marijuana shares were favourites of investors earlier this year but have since suffered setbacks: the vaping crisis in the United States (US) as well as issues on the home front have...

ASX cannabis stock Cann Global Ltd  (ASX: CGB) has seen its share price rocket 8.70% higher today after a key announcement. What is Cann Global? Formerly Queensland Bauxite Limited, the company has undergone significant changes in recent y...

Given it’s chock full of omega acids and other goodies, hemp is acknowledged as one of nature’s finest super foods. But how much of a good thing is too much? The issue has been occupying the collective minds of the US Food and Drug Administ...

In order to boost their returns, investors usually tend to search for stocks of the companies that are likely to report relatively higher revenues and earnings in the future. The stocks that are expected to grow substantially above the aver...

In order to boost their returns, investors usually tend to search for stocks of the companies that are likely to report relatively higher revenues and earnings in the future. The stocks that are expected to grow substantially above the aver...

Althea Group Holdings Ltd (ASX:AGH) shares are in a trading halt pending an announcement, with rumours swirling that major shareholder and supplier Aphria is looking to sell their stake in the Australia marijuana supplier. Althea shares ha...

Amidst the global market fickleness, competition and economic pressure, cannabis stocks stand out as the hot pick stocks for investors.  The Cannabis stocks are gaining traction with the sector growing at a fast pace with new listings and i...

Listed cannabis stocks worldwide have pulled back from their highs lately, tainted by the vaping crisis in the US. Canopy Growth has seen its share price drift down to just above US$20 from highs of over US$50 in April. Rival Aurora Cannab...

In afternoon trade the S&P/ASX 200 index has followed the lead of U.S. markets and is pushing higher. At the time of writing the benchmark index is up 0.3% to 6,671.5 points. Four shares that have failed to follow the market higher tod...

Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished lower on Monday. Here’s a short recap of the Australian market: S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) lower 0.01% to 6...

The Cann Group Ltd (ASX: CAN) share price is down 3.3% to $1.33 this morning after the ‘pot stock’ reported an operating cash loss of $3.55 million on receipts from customers of $1.66 million. It also spent $17.66 million over the quarter...

In the few short years since cannabis companies first floated on stock exchanges around the world, they have developed a reputation for being volatile and high risk. At the start, stocks exploded in value, peaking around the start of 2018....

The Phoslock Environmental Technologies Ltd (ASX: PET) share price is down more than 25% this week after the “environmental technology” business handed in its 4C quarterly cash flow report. For the quarter Phoslock reported a net operating...

Government bodies across the globe are legalising the manufacturing and consumption of medical cannabis products, resulting in vast opportunities for investors. In 2018, Canada became the second largest country in the world to legalise cann...

Cannabis industry in Australia is growing at a fast pace, and government authorities across the country are creating a lot of prospects for investors by legalising medicinal cannabis. Moreover, it is being assumed that the Australia cannabi...

When Ecofibre Ltd (ASX:EOF) released its 4C (quarterly cashflow report) for the three months to 30th September early last week, there was no notable share price reaction. However, we do note straight out of the gates that it was rather earl...

It appears leading Canadian cannabis business Canopy Growth Corp didn’t get the ‘buy low, sell high’ pot stock memo after dumping its 42.08 million shares in Auscann Group Holdings Ltd (ASX: AC8) for just 15 cents per share.  The block tra...

Cannabis Capital Canberra is the capital of Australia, located in the Australian Capital Territory (ACT). The ACT includes the capital of the country and surrounding townships. In historic legislation passed a while ago, the Australian capi...

2018 witnessed several catalysts for the legal cannabis industry, with countries legalising medicinal cannabis, public and private sector getting into constructive discussions about the calibre and cons of the pot industry from a business p...

ASX cannabis shares are struggling to gain momentum in FY19. Interest in the sector has dwindled and sentiment is waning. This could be explained by the short-sighted nature of the market. When there isn’t any groundbreaking news released...

Cannabis company Zelda Therapeutics Ltd (ASX: ZLD) has seen its share price push higher today after it announced a major development. Its shares were up as much as 7.5% to 8.6 cents in morning trade before dropping back a touch. What did Z...

Each Monday, Stockhead recaps which stocks are heavily demanded by investors — or running hot. Stockhead uses the Relative Strength Index (RSI), a technical gauge which measures how trading momentum is affecting the price action. A reading...

Cannabis industry is composed of ancillary products and services, legal cultivators and producers, consumers, researchers, independent industrial standard bodies and regulators. Lately, several companies are getting inclined towards the can...

Although the market is trading within sight of its 52-week high, not all shares have been performing as strongly. Three shares that have just hit 52-week lows or worse are listed below. Here’s why they are down in the dumps: The Cann Group...

The ASX pot stock sector ran hot in 2018 on not much more than media hype, companies spinning stories, and plenty of less-sophisticated investors buying into them. The sector didn’t run higher on share market fundamentals as there were non...

In afternoon trade the S&P/ASX 200 index has given back its early gains and is on course to record another decline. At the time of writing the benchmark index is down 0.3% to 6,687.8 points. Four shares that have fallen more than most...

Usually, when lawmakers take a step further on the road to legalisation, there’s a flurry of speculation around cannabis stocks. However, despite positive news for marijuana enthusiasts from the Australian Capital Territory Legislative Ass...

Elixinol Global (ASX:EXL): It's Not Easy Being Green It’s high time we checked in on Elixinol Global (ASX:EXL) post the release of the company’s 1H19 results late last month and following a very busy last several months which we’ll summaris...

All us Fools are seeking to hit the jackpot on that next investment, but it can be difficult to know where to start. I’ve taken a look at how one big ASX stock bet has the potential to pay off handsomely and make you a millionaire in a mat...

In this day and age, it can be hard to build your portfolio and achieve strong, consistent capital gains in the market. Even the great Warren Buffett himself has seen his market outperformance or “alpha” slowly dwindle over time as we’ve e...

In morning trade the Althea Group Holdings Ltd (ASX: AGH) share price has pushed higher following the release of a market update. At the time of writing the cannabis company’s shares are up 3% to 79.5 cents. What did Althea announce? This...